Explore
Trendline
Daiichi Sankyo Faces $850M Charge Amid Falling ADC Demand Forecast
Daiichi Sankyo Faces $850M Charge Amid Falling ADC Demand Forecast
Read More
Trendline
Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership
Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership
Read More
Trendline
Almirall's European Dermatology Business Drives Q1 2026 Growth
Almirall's European Dermatology Business Drives Q1 2026 Growth
Read More
Trendline
Sumitomo Metal Anticipates Double-Digit Copper Treatment Charges for 2026 Amid Global Smelting Capacity Expansion
Sumitomo Metal Anticipates Double-Digit Copper Treatment Charges for 2026 Amid Global Smelting Capacity Expansion
Read More
Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Read More
Trendline
Nintendo Faces Share Value Decline Amidst Price Hike Concerns
Nintendo Faces Share Value Decline Amidst Price Hike Concerns
Read More
AP News
Trump and Xi dialed down the trade war, but challenges lurk at their China summit
President Donald Trump claims America is profiting from trade with China despite tensions over rare earth minerals, tariffs and emerging technologies like AI
Read More
Reuters
Trading Day: AI beats Iran impasse
By Jamie McGeever ORLANDO, Florida, May 11 (Reuters) - U.S. and world stocks touched new highs on Monday, as artificial intelligence fever continued to outweigh the prolonged U.S.-Iran impasse.
Read More
Trendline
Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials
Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials
Read More
Trendline
Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand
Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand
Read More
Trendline
American Axle Manufacturing Reports Strong Q1 Earnings Amid Dowlais Acquisition
American Axle Manufacturing Reports Strong Q1 Earnings Amid Dowlais Acquisition
Read More
Trendline
Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges
Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges
Read More